Tower Research Capital LLC (Trc) Citius Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,044 shares of CTXR stock, worth $889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,044
Previous 43,521
90.71%
Holding current value
$889
Previous $25,000
92.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding CTXR
# of Institutions
59Shares Held
23.4MCall Options Held
83.1KPut Options Held
32.1K-
Armistice Capital, LLC New York, NY7.28MShares$1.6 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$1.42 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$413,3690.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$397,2590.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.16MShares$254,8710.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $32.1M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...